Charles Casamento

Charles Casamento

Vermögen: 4 Mio $ am 31.08.2026

79 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Charles J.
Casamento
is an Independent Director at GT Biopharma, Inc., an Independent Director at Eton Pharmaceuticals, Inc., a Chairman at Relmada Therapeutics, Inc., an Executive Director & Principal at The Sage Group LLC (Washington), an Independent Director at Astex Pharmaceuticals, Inc. and a Member-Science Council at Fordham University.
He is on the Board of Directors at GT Biopharma, Inc., Eton Pharmaceuticals, Inc., KineMed, Inc., The Sage Group LLC (Washington), Astex Pharmaceuticals, Inc., PaxMedica, Inc. and Sage Healthcare Ltd. Mr. Casamento was previously employed as a Lead Independent Director by PaxMedica, Inc., an Independent Director by Entero Therapeutics, Inc., an Independent Director by International Stem Cell Corp., an Independent Director by VIVUS, Inc., a President & Chief Executive Officer by Osteologix, Inc. /Old/, a Chairman, President & Chief Executive Officer by Questcor Pharmaceuticals, Inc., a Chairman by Cortex Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by RiboGene, Inc., a President & Chief Executive Officer by Interneuron Pharmaceuticals, Inc., a Senior VP-Pharmaceuticals & Biochemicals by Genzyme Corp., a VP-Business Development & Strategic Planning by American Hospital Supply Corp., a Vice Chairman by Catholic Medical Mission Board, Inc., a VP-Business Development & Strategic Planning by Hoffmann-La Roche, Inc., a VP-Business Development & Strategic Planning by Johnson & Johnson, and a VP-Business Development & Strategic Planning by Sandoz, Inc. He also served on the board at SuperGen, Inc. and Mount Saint Michael Academy, Inc. He received his undergraduate degree from Fordham University and an MBA from Iona College.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.07.2026 68.420 ( 0,24 % ) 4 Mio $ 31.08.2026
30.06.2026 62.500 ( 0,14 % ) 17 875 $ 31.08.2026
26.03.2026 0 ( -.--% ) - $ 31.08.2026

Aktive Positionen von Charles Casamento

UnternehmenPositionBeginn
KINEMED INC Direktor/Vorstandsmitglied 01.11.2013
RELMADA THERAPEUTICS, INC. Vorsitzender 15.06.2017
ETON PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 01.06.2017
GT BIOPHARMA, INC. Direktor/Vorstandsmitglied 01.05.2023
PAXMEDICA, INC. Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied 01.05.2007
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 15.09.2011

Ehemalige bekannte Positionen von Charles Casamento

UnternehmenPositionEnde
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Charles Casamento im Detail an

Ausbildung von Charles Casamento

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

64

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Charles Casamento
-40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT